Prior Authorization Clinical Policy Reasoning

Overview

Guide the agent through structured evaluation of prior authorization (PA) clinical policies, coverage determinations, step therapy protocols, and appeals processes. This skill encodes payer policy logic so the agent can assess whether a requested service meets authorization criteria, identify documentation gaps, and recommend appeal strategies.

Usage

• Invoke when evaluating whether a service meets prior authorization clinical criteria
• Use for step therapy evaluation, medical necessity assessment, or appeal strategy
• Activate for CMS LCD/NCD coverage rules or Da Vinci PAS implementation guidance

Core Concepts

Response Format

• Lead with the direct recommendation or classification (≤3 sentences)
• Structure as: recommendation → justification (citing specific criteria/thresholds) → caveats
• Use tables for comparisons; bullet points for criteria lists
• Omit background the user already knows — they asked the question
• Target: 200-400 words unless the user requests exhaustive detail The decision trees and frameworks in this skill are for internal reasoning only. Apply them to reach your conclusion, but do not reproduce them in your response. Present only the final recommendation with supporting evidence.

1. Prior Authorization Decision Framework

When a user asks about a PA decision, follow this sequence:

1. Identify the service type: drug (pharmacy benefit), procedure, DME, or imaging
2. Determine the payer: commercial, Medicare, Medicaid, or Medicare Advantage
3. Locate the applicable policy: formulary, LCD/NCD, or internal clinical criteria
4. Evaluate medical necessity: match diagnosis + clinical evidence to criteria
5. Check step therapy: confirm required prior treatments were attempted
6. Assess documentation completeness: verify all required supporting information
7. Recommend action: approve path, identify gaps, or outline appeal strategy

2. Clinical Criteria Structures

2.1 Medical Necessity Definition

Medical necessity requires ALL of the following:

1. Clinically appropriate: consistent with diagnosis, symptoms, and accepted standards of care
2. Not primarily for convenience: of the patient, provider, or payer
3. Most cost-effective level: among equally effective alternatives
4. Not experimental: FDA-approved or supported by peer-reviewed evidence
5. Expected to improve outcome: measurable clinical benefit anticipated

2.3 Diagnosis-Specific Criteria Examples

3. Step Therapy Requirements

3.1 Step Therapy Logic

Step therapy mandates that lower-cost or first-line treatments are tried before authorizing higher-cost alternatives. The general pattern:

Step 1: Generic / first-line therapy
  ↓ (documented failure, intolerance, or contraindication)
Step 2: Preferred brand / second-line therapy
  ↓ (documented failure, intolerance, or contraindication)
Step 3: Non-preferred / specialty therapy

3.2 Step Therapy Evaluation Rules

1. Adequate trial duration: each step must be tried for the clinically appropriate duration
   • Most oral medications: 30–90 days
   • Biologics: 12–16 weeks
   • Behavioral health: 8–12 weeks
2. Documented failure: objective evidence of inadequate response (lab values, symptom scores)
3. Intolerance: documented adverse effects that preclude continued use
4. Contraindication: clinical reason the step cannot be attempted (allergy, drug interaction, comorbidity)
5. Step skip exceptions: life-threatening conditions, prior step completed at another plan

3.3 Common Step Therapy Sequences

4. CMS Coverage Determinations

4.1 NCD vs LCD

4.2 LCD Evaluation Checklist

When assessing whether a service is covered under an LCD:

• Identify the MAC jurisdiction for the provider's location
• Search the CMS Medicare Coverage Database for active LCDs
• Check the LCD's ICD-10 code list — is the patient's diagnosis included?
• Review the "Indications and Limitations" section for clinical criteria
• Verify the CPT/HCPCS code is listed as covered under the LCD
• Check for any associated billing article with documentation requirements
• Confirm no superseding NCD exists for the same service

5. Formulary Tier Structure

5.1 Formulary Exception Process

1. Standard exception: prescriber submits clinical rationale for non-formulary drug
2. Expedited exception: urgent clinical need, 24-hour turnaround required
3. Tier reduction: request lower cost-sharing based on medical necessity
4. Required documentation: letter of medical necessity, prior treatment history, lab results

6. Appeals Process

6.1 Appeal Levels (Commercial)

6.2 Appeal Levels (Medicare Part C/D)

6.3 Peer-to-Peer Review Best Practices

When preparing for a peer-to-peer review with the payer medical director:

1. Know the specific denial reason: request the denial letter and clinical policy cited
2. Prepare clinical evidence: relevant labs, imaging, treatment history, specialist notes
3. Reference guidelines: cite society guidelines (ACR, NCCN, AAN) supporting the request
4. Document prior treatments: list all failed/tried therapies with dates and outcomes
5. Articulate medical necessity: explain why this specific service is required for this patient
6. Note urgency: if delay poses clinical risk, document the time-sensitive nature

6.4 Documentation Checklist for Appeals

• Copy of the denial letter with specific reason codes
• Letter of medical necessity from treating physician
• Relevant clinical notes (last 6–12 months)
• Lab results supporting the diagnosis and treatment need
• Prior treatment history with dates, doses, and outcomes
• Society guideline excerpts supporting the requested service
• Peer-reviewed literature (if off-label or emerging therapy)
• Patient statement (if relevant to functional impact)

7. FHIR Da Vinci PAS Implementation

7.1 Overview

The Da Vinci Prior Authorization Support (PAS) Implementation Guide defines a FHIR-based workflow for submitting and tracking prior authorization requests. CMS mandates payer support by 2026.

7.2 PAS Workflow Sequence

1. Provider EHR constructs a PAS Bundle with Claim + supporting resources
2. EHR submits $submit operation to payer's PAS endpoint
3. Payer returns ClaimResponse with disposition: approved, denied, or pended
4. If pended, payer may request additional info via CommunicationRequest
5. Provider submits updated Bundle with requested documentation
6. Payer issues final ClaimResponse
7. Provider queries $inquire operation for status updates

When NOT to Use This Skill

• Making coverage determinations for individual patients (requires licensed clinician)
• When payer-specific contracts override published clinical policies
• Adjudicating appeals that require medical record review

When to Escalate to a Human Expert

• Peer-to-peer review preparation (needs treating physician)
• When denial involves experimental/investigational determination
• When state Medicaid rules conflict with commercial payer policies

8. Common Mistakes

• Wrong: Assuming all payers use the same clinical criteria for a given service Right: Always check the specific payer's published clinical policy before submitting a PA request Why: Each payer maintains independent policies; criteria that work for one payer may not apply to another
• Wrong: Skipping step therapy documentation when the patient tried a drug at a prior plan Right: Document all prior treatments with dates, doses, duration, and outcomes — even from previous plans Why: Without documented evidence of prior steps, the payer will deny regardless of actual treatment history
• Wrong: Submitting appeals without addressing the specific denial reason code or cited criteria Right: Reference the exact denial reason and provide evidence directly addressing each unmet criterion Why: Generic appeals that don't target the specific denial rationale are almost always upheld
• Wrong: Applying an LCD from one MAC jurisdiction to a provider in a different MAC's territory Right: Identify the correct MAC jurisdiction for the provider's location and use that MAC's LCD Why: LCDs are jurisdiction-specific; coverage rules from one MAC have no authority in another
• Wrong: Treating LCDs and NCDs as equivalent or interchangeable Right: Always check for an applicable NCD first — NCDs take precedence and cannot be overridden by LCDs Why: An LCD cannot contradict or override a National Coverage Determination
• Wrong: Missing formulary exception deadlines, especially for expedited requests Right: Track and meet all turnaround requirements — 24 hours for expedited exceptions Why: Missed deadlines result in automatic denials and delayed patient access to needed medications
• Wrong: Conducting peer-to-peer reviews without citing published clinical guidelines Right: Reference specific society guidelines (ACR, NCCN, AAN) that support the requested service Why: Peer-to-peer reviews are significantly more effective when backed by authoritative guideline citations
• Wrong: Attaching clinical documentation as unstructured PDFs in Da Vinci PAS bundles Right: Structure clinical documentation in the supportingInfo field using proper FHIR resource references Why: Unstructured attachments cannot be processed by automated adjudication systems, causing delays
• Wrong: Applying commercial appeal timelines and processes to Medicare PA requests Right: Use Medicare-specific appeal levels and timelines (redetermination → IRE → ALJ → MAC → Federal court) Why: Medicare has distinct appeal levels, timelines, and amount-in-controversy thresholds
• Wrong: Failing to track PA expiration dates after authorization is granted Right: Monitor authorization validity periods and reauthorize before expiration if services are ongoing Why: Services rendered after PA expiration require new authorization — retroactive approval is rarely granted

9. Decision Tree: PA Request Evaluation

Is the service on the payer's PA-required list?
├── NO → No PA needed; proceed with service
└── YES
    ├── Is there an applicable NCD?
    │   ├── YES → Does the request meet NCD criteria?
    │   │   ├── YES → Approve (document NCD compliance)
    │   │   └── NO → Deny (cite NCD; appeal to ALJ if Medicare)
    │   └── NO → Check for LCD or plan-specific policy
    │       ├── LCD exists → Evaluate LCD criteria
    │       └── Plan policy exists → Evaluate plan criteria
    │           ├── Medical necessity met?
    │           │   ├── YES → Check step therapy
    │           │   │   ├── Step therapy satisfied → Approve
    │           │   │   └── Step therapy NOT satisfied
    │           │   │       ├── Exception applies? → Approve with exception
    │           │   │       └── No exception → Deny (cite step therapy)
    │           │   └── NO → Deny (cite medical necessity)
    │           └── Documentation incomplete?
    │               └── Pend for additional information

10. Quick Reference: Denial Reason Categories

11. PA Turnaround Time Requirements

Urgency Determination Rules

A request qualifies as expedited when:

1. Applying standard timeframe could seriously jeopardize the patient's life or health
2. Applying standard timeframe could jeopardize the patient's ability to regain maximum function
3. A physician indicates the request is urgent (physician attestation)
4. The patient is currently undergoing treatment that would be interrupted

12. Quantity Limits and Site-of-Care Policies

12.1 Quantity Limit Structures

12.2 Site-of-Care Optimization

Payers increasingly require lower-cost sites for infusion and injection therapies:

Is the drug available for home infusion?
├── YES → Home infusion preferred (lowest cost)
│   ├── Patient clinically stable? → Approve home infusion
│   └── Patient requires monitoring? → Approve outpatient infusion center
└── NO → Is outpatient infusion center available?
    ├── YES → Outpatient preferred over hospital outpatient
    └── NO → Hospital outpatient department approved

13. Regulatory Timeline: Key PA Reform Dates

Gold Carding Programs

Several states require payers to exempt providers from PA if they demonstrate ≥90% approval rate for a specific service over 12 months. Exemption lasts 12 months, subject to audit, and is revoked if approval rate drops below threshold.